Anette Weber appointed as new Ascom CFO

May 24, 2017

Anette Weber, a successful CFO with a solid track record and broad international experience, has been appointed by the Board of Directors of Ascom Holding AG as new CFO of the Ascom Group. Bianka Wilson is leaving Ascom after four years of service in order to pursue new professional opportunities.

Ascom has appointed a new Chief Financial Officer and selected Anette Weber, an experienced finance expert with a solid track record and a broad international background, as new CFO. Anette Weber (46) has worked for the Novartis Group for 20 years in different management positions and acquired extensive expertise in financial and general management, IT, and Corporate Governance.

Anette Weber, who will also become a member of the Executive Board, will take full responsibility for her new position as of 1 August 2017. The current CFO, Bianka Wilson, has decided to leave Ascom and to pursue new career opportunities.

The Board of Directors and the Executive Committee welcome Anette Weber as new CFO of the Ascom Group. At the same time, they take the opportunity to thank Bianka Wilson for her commitment and her valuable contribution in the last four years, including the transformation of Ascom into a One-Business Company. They wish her all success for the future.

"I am pleased about the appointment of Anette Weber as new CFO. Going forward, the operational finance management and controlling plays a key role in the further strategic development of Ascom. Anette Weber will strengthen our management team and make an important contribution to the achievement of our ambitious targets", underlines Holger Cordes, CEO of Ascom.

About Anette Weber

Born 1971

Nationality German

1997 Lic .oec. HSG in Business Administration,
University of St. Gallen

1997 - 1999 International Controller,
Novartis Animal Health Inc., Basel

1999 - 2005 Head of Finance and IT / then Country Head Japan
Novartis Animal Health K.K, Tokyo

2005 CFO (Kfm. Geschäftsführerin)
Sandoz Pharma GmbH, Munich

2006 - 2009 CFO
Lek.d.d., Ljubljana (Slovenia)

2009 - 2014 CFO Biopharma & Oncology
Sandoz International GmbH, Holzkirchen (Germany)

2014 - 2016 Global Head Finance Pharma Development
Novartis Pharma AG, Basel

Since 2016 Global Lead Development Transformation
Novartis AG, Basel

Since 2013 Member of the Supervisory Board and Chairwoman
of the Audit Committee
XING AG, Hamburg

You may request a picture of Anette Weber at


This document does not constitute an offer or solicitation to subscribe for, purchase or sell any securities. This document is not being issued in the United States of America or the United Kingdom and should not be distributed in any jurisdiction in a manner where such distribution would not comply with regulatory requirements. In particular, this document may not be distributed into the United States, to United States persons or to publications with a general circulation in the United States. In addition, the securities of Ascom have not been and will not be registered in any jurisdiction outside Switzerland. The securities of Ascom may not be offered, sold or delivered and no solicitation to purchase such securities may be made within the United States or to U.S. persons absent an applicable exemption from the registration requirements of the United States securities laws or within any other jurisdiction and in a manner where such offer, sale, delivery or solicitation might not be in compliance with regulatory requirements (including the United Kingdom).